We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer.
- Authors
McCabe, N; Cerone, M A; Ohishi, T; Seimiya, H; Lord, C J; Ashworth, A
- Abstract
The BRCA1 and BRCA2 proteins are involved in the maintenance of genome stability and germ-line loss-of-function mutations in either BRCA1 or BRCA2 strongly predispose carriers to cancers of the breast and other organs. It has been demonstrated previously that inhibiting elements of the cellular DNA maintenance pathways represents a novel therapeutic approach to treating tumors in these individuals. Here, we show that inhibition of the telomere-associated protein, Tankyrase 1, is also selectively lethal with BRCA deficiency. We also demonstrate that the selectivity caused by inhibition of Tankyrase 1 is associated with an exacerbation of the centrosome amplification phenotype associated with BRCA deficiency. We propose that inhibition of Tankyrase 1 could be therapeutically exploited in BRCA-associated cancers.
- Publication
Oncogene, 2009, Vol 28, Issue 11, p1465
- ISSN
1476-5594
- Publication type
Journal Article
- DOI
10.1038/onc.2008.483